InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by GERSHWIND ERIK, Président. Officer active across 1 companies, notably MSC Industrial Direct Co INC. Cumulatively, 10 reports have been published. The latest transaction was disclosed on 16 November 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations10 total
€4m84,059 shares@ €51.8190.075% mcap100.0% of flow
Class A Common Stock, $0.001 par value
SEC:0001003078-21-000244·
€4m84,059 shares@ €51.8190.075% mcap50.0% of flow
Class A Common Stock, $0.001 par value
SEC:0001003078-21-000244:0·
07,984 shares0
Class A Common Stock, $0.001 par value
SEC:0001003078-21-000235·
07,984 shares0
Class A Common Stock, $0.001 par value
SEC:0001003078-21-000235:0·
02,314 shares0
Class A Common Stock, $0.001 par value
SEC:0001003078-21-000217·
02,314 shares0
Class A Common Stock, $0.001 par value
SEC:0001003078-21-000217:0·
02,764 shares0
Class A Common Stock, $0.001 par value
SEC:0001003078-21-000209·
02,764 shares0
Class A Common Stock, $0.001 par value
SEC:0001003078-21-000209:0·
03,305 shares0
Class A Common Stock, $0.001 par value
SEC:0001003078-21-000189·
03,305 shares0
Class A Common Stock, $0.001 par value
SEC:0001003078-21-000189:0·
10 of 10 declarations
About GERSHWIND ERIK
Srdjan R. Stankovic serves as President of Acadia Pharmaceuticals Inc. In this role, he is responsible for the strategic direction of the company and the management of operations. Srdjan plays a key role in developing new therapies and optimizing the performance of the biopharmaceutical company.
